Soleus Capital Management, L.P. Quant / Systematic

Location: Greenwich, CT

CIK: 0001802630 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value: $85.94M (99.8% shares, 0.2% debt)

Holdings (48)

ESSA PHARMA INC 9.7%
Value $8.322M Shares 2,080,421 Est. Cost $5.18 Unrealized
GRFS GRIFOLS S A 9.1%
Value $7.795M Shares 387,035 Est. Cost $23.29 Unrealized
IVERIC BIO INC 6.4%
Value $5.529M Shares 1,607,153 Est. Cost $5.58 Unrealized
HARPOON THERAPEUTICS INC 6.3%
Value $5.453M Shares 470,926 Est. Cost $12.42 Unrealized
IRMD IRADIMED CORP 5.8%
Value $5.013M Shares 234,810 Est. Cost $21.52 Unrealized +1.1%
ALEXION PHARMACEUTICALS INC 5.0%
Value $4.292M Shares 47,800 Est. Cost $101.81 Unrealized
ZYXIQ ZYNEX INC 4.5%
Value $3.859M Shares 348,564 Est. Cost $9.73 Unrealized 0.0%
DXCM DEXCOM INC 4.2%
Value $3.622M Shares 13,450 Est. Cost $47.43 Unrealized +31.2%
VCEL VERICEL CORP 3.8%
Value $3.231M Shares 352,332 Est. Cost $16.05 Unrealized -6.6%
ADVERUM BIOTECHNOLOGIES INC 3.6%
Value $3.067M Shares 313,900 Est. Cost $11.52 Unrealized
EIGER BIOPHARMACEUTICALS INC 3.2%
Value $2.755M Shares 405,207 Est. Cost $10.90 Unrealized
ALLERGAN PLC 3.0%
Value $2.586M Shares 14,600 Est. Cost $191.16 Unrealized
AEGLEA BIOTHERAPEUTICS INC 2.9%
Value $2.5M Shares 536,497 Est. Cost $7.20 Unrealized
MISONIX INC 2.6%
Value $2.245M Shares 238,333 Est. Cost $16.30 Unrealized
ZYMEWORKS INC 2.5%
Value $2.182M Shares 61,528 Est. Cost $39.14 Unrealized
ANTARES PHARMA INC 2.4%
Value $2.039M Shares 864,100 Est. Cost $2.36 Unrealized
ABBV ABBVIE INC 2.3%
Value $2.019M Shares 26,500 Est. Cost $67.19 Unrealized 0.0%
UNH UNITEDHEALTH GROUP INC 2.3%
Value $1.97M Shares 7,900 Est. Cost $249.73 Unrealized 0.0%
AXONICS MODULATION TECHNOLOG 1.9%
Value $1.601M Shares 63,000 Est. Cost $25.41 Unrealized
ITAMAR MED LTD 1.6%
Value $1.353M Shares 114,865 Est. Cost $11.78 Unrealized
RFL RAFAEL HLDGS INC 1.3%
Value $1.142M Shares 89,131 Est. Cost $17.79 Unrealized -1.8%
KADMON HLDGS INC 1.3%
Value $1.077M Shares 257,141 Est. Cost $4.53 Unrealized
ZAFGEN INC 1.2%
Value $1.038M Shares 1,348,399 Est. Cost $0.97 Unrealized
BIIB BIOGEN INC 1.1%
Value $949K Shares 3,000 Est. Cost $277.46 Unrealized +9.4%
ESTA ESTABLISHMENT LABS HLDGS INC 1.1%
Value $914K Shares 63,254 Est. Cost $22.15 Unrealized -0.4%
AXGN AXOGEN INC 0.9%
Value $781K Shares 75,050 Est. Cost $14.78 Unrealized -13.9%
MILLENDO THERAPEUTICS INC 0.9%
Value $778K Shares 147,406 Est. Cost $5.28 Unrealized
PTCT PTC THERAPEUTICS INC 0.8%
Value $727K Shares 16,300 Est. Cost $47.07 Unrealized +7.0%
CRSP CRISPR THERAPEUTICS AG 0.8%
Value $696K Shares 16,400 Est. Cost $54.60 Unrealized -5.4%
FOLD AMICUS THERAPEUTICS INC 0.8%
Value $665K Shares 72,000 Est. Cost $9.15 Unrealized +3.8%
CONSTELLATION PHARMCETICLS I 0.7%
Value $563K Shares 17,900 Est. Cost $47.10 Unrealized
ENTA ENANTA PHARMACEUTICALS INC 0.6%
Value $545K Shares 10,600 Est. Cost $53.30 Unrealized 0.0%
CTSO CYTOSORBENTS CORP 0.6%
Value $538K Shares 69,600 Est. Cost $5.05 Unrealized 0.0%
LIVONGO HEALTH INC 0.6%
Value $516K Shares 18,100 Est. Cost $25.26 Unrealized
SHOCKWAVE MED INC 0.5%
Value $404K Shares 12,185 Est. Cost $37.91 Unrealized
NVCR NOVOCURE LTD 0.4%
Value $377K Shares 5,597 Est. Cost $79.03 Unrealized 0.0%
RLMD RELMADA THERAPEUTICS INC 0.4%
Value $375K Shares 11,000 Est. Cost $40.32 Unrealized 0.0%
AMARIN CORP PLC 0.4%
Value $360K Shares 90,000 Est. Cost $4.00 Unrealized
STAA STAAR SURGICAL CO 0.3%
Value $252K Shares 7,798 Est. Cost $32.99 Unrealized +2.1%
TCR2 THERAPEUTICS INC 0.3%
Value $237K Shares 30,624 Est. Cost $7.74 Unrealized
PCRX PACIRA BIOSCIENCES 0.3%
Value $235K Shares 7,000 Est. Cost $41.54 Unrealized 0.0%
SNDX SYNDAX PHARMACEUTICALS INC 0.3%
Value $230K Shares 20,980 Est. Cost $7.34 Unrealized +27.8%
ADURO BIOTECH INC 0.3%
Value $222K Shares 81,200 Est. Cost $2.73 Unrealized
AYTU BIOSCIENCE INC 0.2%
Value $209K Shares 139,600 Est. Cost $1.50 Unrealized
VNDA VANDA PHARMACEUTICALS INC 0.2%
Value $197K Shares 19,000 Est. Cost $12.40 Unrealized 0.0%
REVANCE THERAPEUTICS INC 0.2%
Value $176K Shares 11,869 Est. Cost $16.21 Unrealized
XENE XENON PHARMACEUTICALS INC 0.2%
Value $150K Shares 13,228 Est. Cost $10.52 Unrealized +35.4%
INSMED INC 0.2%
Value $150K Shares 180,000 Est. Cost $0.83 Unrealized